Cerus | Sustainability Performance
Develops technologies and products for blood safety and transfusion medicine.
1992
United States
201 - 500 employees
Biotechnology
$100M - 500M in revenue
Not profitable
Sustainability Ranking & Industry Benchmark
#9184
Overall#2056
in United States#190
in BiotechnologySustainability Maturity
Sustainability Intent
Overview
Governance
TargetsESG scores and ExclusionsFinancial Data
Business performanceCapital & innovationAnalyst projections
Market cap
Revenue
R&D intensity
Controversy level
Powered by illuminem
Market cap
Revenue
EBITDA
Operating margin
P/E ratio
Revenue & EBITDA
$201.0MFY2024 revenue
Total Annual
Revenue & EBITDA
($ B)
Annual revenue
EBITDA
3 year change
Revenue by region
Revenue by region %
BELGIUM
Europe, middle east and africa.
FRANCE
KUWAIT
North America
Other.
Other countries.
UNITED STATES
Powered by illuminem
Margin trends
Margin as % of revenue
Gross margin
Operating margin
Net margin
Powered by illuminem
Free cashflow
Capex
Debt/equity ratio
R&D intensity
28.9%FY2024
R&D as % of revenue
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Return on invested capital
-15.0%FY2026
Return on invested capital (ROIC)
Industry benchmark
Powered by illuminem
Analyst revenue estimates & actuals
Analyst consensus vs actuals
($ B)
Actual revenue
Consensus estimates
Estimate only
0.2
▲ 6.3%
0.2
▲ 11.5%
0.2
▲ 10.9%
0.3
2027Powered by illuminem
Environmental policy coverage
Carbon reduction policy
Not available
Human rights policy
Not available
Recycling policy
Not available
Workplace health & safety policy
Available
50%
Independent Directors
6 out of 12 incl. management
Overall score
35
Environment
4
Social
39
Governance
63
Exclusion screening
Adult content
Not available
Alcoholic
Not available
Animal testing
Available
Firearms
Not available
Tobacco
Not available
Gambling
Not available
Nuclear
Not available
